Dosage Form: Formas farmacéuticas inhaladas, incluidos inhaladores de polvo seco (DPI) y soluciones/suspensiones para inhalación de administración pulmonar y nasal
Bioavailability Enhancement: Desarrollo de formulación y proceso centrado en optimizar el depósito y la absorción pulmonar y nasal, respaldado por una sólida experiencia en administración inhalada
Scale Capability: Fabricación y suministro clínico que abarca las Fases I-III, respaldados por equipos de secado por aspersión, micronización, mezcla y encapsulación

Otra información

Descripción adicional:

With a 30-year track record in developing and manufacturing inhaled drug products, this team has experience across delivery platforms including dry powder inhalers (DPIs) and inhalation solutions/suspensions. Integrated capabilities and deep nasal and pulmonary delivery expertise help clients move molecules from first-in-human studies through proof of concept and into full development, covering pre-formulation and API characterization, formulation and process development, inhaled device evaluation and selection, clinical manufacturing and supply across Phases I-III, and clinical pharmacology assessments, supported by a wide range of processing and analytical equipment including spray drying, micronization, and blending and encapsulation.